Enzon Pharmaceuticals, Inc. (ENZN)
USD 0.1
(0.0%)
USD 0.1
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | 26 Thousand | 701 Thousand | 52 Thousand | 207 Thousand | 6.91 Million |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | 26 Thousand | 701 Thousand | 52 Thousand | 207 Thousand | 6.91 Million |
| Operating Expenses | 1.04 Million | 1.05 Million | 1.17 Million | 1.35 Million | 1.18 Million | 1.06 Million |
| Selling, General and Administrative Expenses | 1.04 Million | 1.05 Million | 1.17 Million | 1.35 Million | 1.18 Million | 1.06 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 646 Thousand | 7000.00 | 1000.00 | - | - |
| Cost and Expenses | 1.04 Million | 1.05 Million | 1.17 Million | 1.35 Million | 1.18 Million | 1.06 Million |
| Operating Income | -1.04 Million | -1.03 Million | -469 Thousand | -1.3 Million | -973 Thousand | 5.85 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -156 Thousand | -200 Thousand | 7000.00 | 7000.00 | 6000.00 | 6000.00 |
| Earnings before Tax | 1.21 Million | -386 Thousand | -462 Thousand | -1.3 Million | -973 Thousand | 5.85 Million |
| Net Income | 98 Thousand | -186 Thousand | -469 Thousand | -1.31 Million | -979 Thousand | 5.84 Million |
| Earnings Per Share Basic | 0.00 | -0.00 | -0.01 | -0.03 | -0.02 | 0.13 |
| Earnings Per Share Diluted | 0.00 | -0.00 | -0.01 | -0.03 | -0.02 | 0.13 |
| Weighted Average Shares Outstanding | 74.24 Million | 74.21 Million | 74.21 Million | 51.1 Million | 44.21 Million | 44.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 74.21 Million | 74.21 Million | 74.21 Million | 51.1 Million | 44.21 Million | 44.21 Million |
| Gross Margin | - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | - | -39.69 | -0.67 | -25.10 | -4.70 | 0.85 |
| Profit Margin | - | -7.15 | -0.67 | -25.21 | -4.73 | 0.85 |
| EBITDA | 1.21 Million | - | - | - | -973 Thousand | 5.85 Million |
| Earnings Before Tax Margin | - | -39.69 | -0.67 | -25.10 | -4.70 | 0.85 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | 26 Thousand | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | 26 Thousand | - | - | - | - |
| Operating Expenses | 351 Thousand | 351 Thousand | 326 Thousand | 216 Thousand | 1.04 Million | 225 Thousand |
| Selling, General and Administrative Expenses | 351 Thousand | 351 Thousand | 326 Thousand | 216 Thousand | - | 225 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 351 Thousand | 351 Thousand | 326 Thousand | 216 Thousand | 1.04 Million | 225 Thousand |
| Operating Income | 205 Thousand | -325 Thousand | -326 Thousand | -216 Thousand | -1.04 Million | -225 Thousand |
| Interest Expense | - | - | - | 447 Thousand | - | - |
| Income Tax Expense | -49 Thousand | 4000.00 | 1000.00 | -249 Thousand | -156 Thousand | 76 Thousand |
| Earnings before Tax | 303 Thousand | 280 Thousand | 321 Thousand | 423 Thousand | 1.21 Million | 397 Thousand |
| Net Income | 254 Thousand | 276 Thousand | 320 Thousand | 672 Thousand | 1.37 Million | 321 Thousand |
| Earnings Per Share Basic | 0.00 | -0.00 | -0.00 | 0.01 | - | -0.00 |
| Earnings Per Share Diluted | 0.00 | -0.00 | -0.00 | 0.01 | - | -0.00 |
| Weighted Average Shares Outstanding | 74.21 Million | 74.21 Million | 74.21 Million | 74.21 Million | 74.21 Million | 74.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 74.21 Million | 74.21 Million | 74.21 Million | 74.21 Million | 74.21 Million | 74.21 Million |
| Gross Margin | - | 1.00 | - | - | - | - |
| EBIT Margin | - | -12.50 | - | - | - | - |
| Profit Margin | - | 10.62 | - | - | - | - |
| EBITDA | 205 Thousand | -325 Thousand | -326 Thousand | -216 Thousand | - | -225 Thousand |
| Earnings Before Tax Margin | - | -12.50 | - | - | - | - |
FZR
JRONF
IDEX
COLORCHIPS
BTR
600303